In lung cancer, 3 fusion partners of ALK have been reported—EML4, TFG, and KIF5B—although the presence of TFG-ALK in lung cancer has not yet been proven with histopathological evidence [9], [10], [11]. The gene discussed is KIF5B; the disease is lung cancer.